ArticleCureus2024
Exploring the Versatility of Transconjunctival Blepharoplasty: A Retrospective Single-Center Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Transconjunctival blepharoplasty using the postseptal technique provides direct access to orbital fat, offering reduced risk of complications, such as ectropion, entropion, fat over-resection, and inferior oblique muscle palsy. This study aims to evaluate the clinical outcomes and safety of transconjunctival blepharoplasty using the postseptal technique, focusing on the incidence of postoperative complications, the recovery time, and the feasibility of combining ancillary procedures with this approach. Methods In this retrospective observational study, we analyzed the outcomes of 88 patients who underwent transconjunctival postseptal blepharoplasty at a private hospital in northern India between July 2022 and January 2024. The patients, aged 20 to 76 years, received either general or local anesthesia. Follow-up assessments occurred at one, two, three, six, and 12 weeks postoperatively. Results The study population was composed of 28 men and 60 women, and the median age was 48 years. Of these patients, 31 underwent concurrent excess skin excision, 19 had additional canthoplasty or canthopexy, and 87 received fat transfer to correct a negative vector. Postoperative swelling, bruising, and chemosis were common, typically resolving within one to two weeks. Fourteen patients reported foreign body sensation, which resolved within 48 to 72 hours. The average time for the resumption of social activities was two weeks. Conclusions Transconjunctival blepharoplasty offers benefits such as reduced swelling, bruising, and risk of lid retraction, along with faster recovery, when compared to transcutaneous approach. Ancillary procedures can be safely combined with this approach. Further research is warranted to explore the long-term outcomes and efficacy of this technique across diverse patient populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.